User profiles for Eleni Liapi
Eleni LiapiAssistant Professor, Johns Hopkins University School of Medicine Verified email at jhmi.edu Cited by 4618 |
New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer
Background: In the fight against cancer, new drug delivery systems are attractive to improve
drug targeting of tumors, maximize drug potency, and minimize systemic toxicity. We studied …
drug targeting of tumors, maximize drug potency, and minimize systemic toxicity. We studied …
Transcatheter intraarterial therapies: rationale and overview
Transcatheter intraarterial therapies have proved valuable in the battle against primary and
secondary hepatic malignancies. The unique aspects of all such therapies are their reduced …
secondary hepatic malignancies. The unique aspects of all such therapies are their reduced …
The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma
PURPOSE: To assess treatment response of hepatocellular carcinoma (HCC) after
transarterial chemoembolization (TACE) with use of diffusion and dynamic contrast medium–…
transarterial chemoembolization (TACE) with use of diffusion and dynamic contrast medium–…
[PDF][PDF] Transcatheter and ablative therapeutic approaches for solid malignancies
E Liapi, JFH Geschwind - Journal of Clinical Oncology, 2007 - Citeseer
The purpose of this article is to present in a concise manner an overview of the most widely
used locoregional transcatheter and ablative therapies for solid malignancies. An extensive …
used locoregional transcatheter and ablative therapies for solid malignancies. An extensive …
Unresectable Hepatocellular Carcinoma: Serial Early Vascular and Cellular Changes after Transarterial Chemoembolization as Detected with MR Imaging1
IR Kamel, E Liapi, DK Reyes, M Zahurak, DA Bluemke… - Radiology, 2009 - pubs.rsna.org
Purpose: To prospectively assess serial changes in contrast material–enhanced and
diffusion-weighted (DW) magnetic resonance (MR) imaging values within 1 month after …
diffusion-weighted (DW) magnetic resonance (MR) imaging values within 1 month after …
Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis
Background Many patients with intrahepatic cholangiocarcinoma (ICC) present with advanced
and inoperable disease. Data on the safety and efficacy of intra-arterial therapy (IAT) for …
and inoperable disease. Data on the safety and efficacy of intra-arterial therapy (IAT) for …
Distribution of iron oxide–containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and …
KH Lee, E Liapi, JA Vossen, M Buijs, VP Ventura… - Journal of Vascular and …, 2008 - Elsevier
PURPOSE: To test whether different-sized iron oxide–containing Embosphere (IOE)
particles can be detected by dedicated magnetic resonance (MR) imaging when injected …
particles can be detected by dedicated magnetic resonance (MR) imaging when injected …
Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization?
E Liapi, JFH Geschwind - Cardiovascular and interventional radiology, 2011 - Springer
Conventional transcatheter arterial chemoembolization and chemoembolization with drug-eluting
beads are increasingly being performed interchangeably in many institutions …
beads are increasingly being performed interchangeably in many institutions …
Lack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment?
…, JF Geschwind, N Harrison, A Hines-Peralta, E Liapi… - Radiology, 2012 - pubs.rsna.org
Purpose To (a) evaluate the response of hepatocellular carcinoma (HCC) to chemoembolization
after initial nonresponse, as determined with European Association for the Study of the …
after initial nonresponse, as determined with European Association for the Study of the …
Platelets take up the monoclonal antibody bevacizumab
Purpose: One of the key factors that promotes angiogenesis is vascular endothelial growth
factor (VEGF). Platelets are the main source of VEGF in blood and contribute to angiogenesis …
factor (VEGF). Platelets are the main source of VEGF in blood and contribute to angiogenesis …